Literature DB >> 30771641

Managing suicidality within specialized care: A randomized controlled trial.

Wenche Ryberg1, Per-Henrik Zahl2, Lien My Diep3, Nils Inge Landrø4, Roar Fosse5.   

Abstract

BACKGROUND: Suicide prevention is a core task in mental health services. Our objective was to determine whether Collaborative Assessment and Management of Suicidality (CAMS) reduced suicidal thoughts and behaviors and mental health distress more effectively than treatment as usual (TAU) in a heterogeneous patient population within specialized mental health care services.
METHODS: In this observer-blinded pragmatic randomized controlled trial participants who scored 13 or above on Beck's Scale for Suicide Ideation-Current (BSSI-C) were included from seven in- and outpatient units. Primary outcome was suicidal ideation (BSSI-C). Secondary outcomes were mental health distress measured by the Outcome Questionnaire-45, and suicidal behaviors measured by the Suicide Attempt Self-Injury Count. Patients were assessed at baseline and after 6 and 12 months.
RESULTS: The final intent-to-treat analyses included 78 participants (mean age 35.9 years, SD = 14.5, 41 females). The majority were depressed (65%), had a secondary diagnosis (73%) and 32% suffered from borderline personality disorder or borderline traits. After 6 months, CAMS participants reported lower levels of suicidal ideation compared to TAU (β = -4.29, 95% CI = -8.32 to -0.27, p = .036). Larger changes in mental health distress were observed for CAMS participants after 6 months (β = -11.87, 95% CI = -22.99 to -0.76, p = .036) and 12 months (β = -13.70, 95% CI = -24.88 to -2.51, p = .017). LIMITATIONS: The modest sample size rendered the trial unable to detect small between-group differences.
CONCLUSIONS: CAMS reduced suicidal ideation and mental health distress more efficiently than TAU in a heterogeneous patient population within specialized care.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Collaboration; Psychotherapy; Randomized controlled trial; Self-harm; Suicidal ideation; Suicide specific treatment model

Mesh:

Substances:

Year:  2019        PMID: 30771641     DOI: 10.1016/j.jad.2019.02.022

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Psychosocial interventions for self-harm in adults.

Authors:  Katrina G Witt; Sarah E Hetrick; Gowri Rajaram; Philip Hazell; Tatiana L Taylor Salisbury; Ellen Townsend; Keith Hawton
Journal:  Cochrane Database Syst Rev       Date:  2021-04-22

2.  Costs, benefits, and cost-benefit of Collaborative Assessment and Management of Suicidality versus enhanced treatment as usual.

Authors:  Phoebe K McCutchan; Brian T Yates; David A Jobes; Amanda H Kerbrat; Katherine Anne Comtois
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240

3.  Impact of intensive treatment programs for posttraumatic stress disorder on suicidal ideation in veterans and service members.

Authors:  Loren M Post; Philip Held; Dale L Smith; Kathryn Black; Rebecca Van Horn; Mark H Pollack; Barbara O Rothbaum; Sheila A M Rauch
Journal:  Psychol Serv       Date:  2021-04-08

4.  A Randomized Controlled Trial of the Collaborative Assessment and Management of Suicidality (CAMS) Versus Treatment as Usual (TAU) for Suicidal College Students.

Authors:  Jacqueline Pistorello; David A Jobes; Robert Gallop; Scott N Compton; Nadia Samad Locey; Josephine S Au; Samantha K Noose; Joseph C Walloch; Jacquelyn Johnson; Maria Young; Yani Dickens; Patricia Chatham; Tami Jeffcoat
Journal:  Arch Suicide Res       Date:  2020-04-10

Review 5.  One Size Does Not Fit All: A Comprehensive Clinical Approach to Reducing Suicidal Ideation, Attempts, and Deaths.

Authors:  David A Jobes; Samantha A Chalker
Journal:  Int J Environ Res Public Health       Date:  2019-09-26       Impact factor: 3.390

6.  Collaborative Assessment and Management of Suicidality (CAMS) compared to enhanced treatment as usual (E-TAU) for suicidal patients in an inpatient setting: study protocol for a randomized controlled trial.

Authors:  Miriam Santel; Thomas Beblo; Frank Neuner; Michaela Berg; Kristina Hennig-Fast; David A Jobes; Martin Driessen
Journal:  BMC Psychiatry       Date:  2020-04-22       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.